Alkermes Plc (ALKS)
46.03
+0.20
(+0.44%)
USD |
NASDAQ |
Sep 15, 16:00
45.50
-0.53
(-1.15%)
Pre-Market: 09:19
Alkermes Price : 46.03 for Sept. 15, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | 45.73 | 46.14 | 44.63 | 46.03 | 2.151M |
| Sep 14, 2026 | 46.60 | 46.60 | 45.66 | 45.83 | 2.029M |
| Sep 11, 2026 | 46.75 | 46.75 | 45.73 | 45.97 | 1.283M |
| Sep 10, 2026 | 44.98 | 46.11 | 44.75 | 46.11 | 1.194M |
| Sep 09, 2026 | 45.24 | 45.60 | 44.72 | 45.40 | 1.443M |
| Sep 08, 2026 | 45.20 | 46.53 | 44.63 | 45.49 | 1.356M |
| Sep 04, 2026 | 46.14 | 46.93 | 45.80 | 46.10 | 1.064M |
| Sep 03, 2026 | 48.01 | 48.29 | 46.71 | 46.88 | 974513.0 |
| Sep 02, 2026 | 47.70 | 48.74 | 46.68 | 47.72 | 1.566M |
| Sep 01, 2026 | 47.00 | 47.34 | 46.65 | 47.20 | 1.351M |
| Aug 31, 2026 | 47.25 | 47.56 | 46.46 | 46.99 | 1.441M |
| Aug 28, 2026 | 48.82 | 48.82 | 47.25 | 47.41 | 1.429M |
| Aug 27, 2026 | 48.72 | 49.33 | 48.10 | 48.90 | 2.119M |
| Aug 26, 2026 | 49.23 | 49.35 | 48.46 | 49.16 | 660877.0 |
| Aug 25, 2026 | 48.94 | 49.58 | 48.87 | 49.21 | 1.127M |
| Aug 24, 2026 | 48.05 | 49.03 | 47.64 | 48.87 | 1.297M |
| Aug 21, 2026 | 48.05 | 48.67 | 47.33 | 48.33 | 939640.0 |
| Aug 20, 2026 | 49.37 | 49.86 | 47.93 | 48.02 | 1.635M |
| Aug 19, 2026 | 51.26 | 51.29 | 50.08 | 50.18 | 1.544M |
| Aug 18, 2026 | 50.10 | 50.42 | 49.46 | 49.48 | 970918.0 |
| Aug 17, 2026 | 48.90 | 50.08 | 48.62 | 49.85 | 764041.0 |
| Aug 14, 2026 | 49.37 | 50.02 | 48.65 | 49.06 | 1.268M |
| Aug 13, 2026 | 51.66 | 51.66 | 49.21 | 49.45 | 1.547M |
| Aug 12, 2026 | 49.22 | 50.53 | 48.50 | 50.28 | 1.316M |
| Aug 11, 2026 | 49.92 | 50.14 | 48.97 | 49.21 | 1.374M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amarin Corp. Plc | 13.93 |
| Jazz Pharmaceuticals Plc | 240.83 |
| Prothena Corp. Plc | 8.33 |
| Biogen, Inc. | 216.17 |
| Cytokinetics, Inc. | 69.31 |
Price Related Metrics
| PE Ratio | 119.56 |
| PS Ratio | 4.677 |
| Price to Book Value | 4.264 |
| Price to Free Cash Flow | 35.19 |
| Earnings Yield | 0.84% |
| Market Cap | 7.712B |
| Operating PE Ratio | 54.28 |
| Normalized PE Ratio | 93.63 |